Australian Senate to Health Authorities: Act on DePuy

  • 295 views
Uploaded on

http://www.depuyhipreplacementlawsuit.com/ - A Senate committee in Australia has asked its health officers to take action against Johnson & Johnson for the trouble that is caused by its DePuy …

http://www.depuyhipreplacementlawsuit.com/ - A Senate committee in Australia has asked its health officers to take action against Johnson & Johnson for the trouble that is caused by its DePuy Articular Surface Replacement (ASR) hip systems which means that the implant manufacturer is not only in trouble in the United States but also in Australia.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
295
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. As Published on the DePuy Hip Replacement Website
  • 2. A Senate committee in Australia has asked its health officers to take action against Johnson & Johnson for the trouble that is caused by its DePuy Articular Surface Replacement (ASR) hip systems which means that the implant manufacturer is not only in trouble in the United States but also in Australia. According to the Senate community affairs references committee, the suffering that the hip implant has caused to hundreds of patients is “intolerable and unacceptable”. Facing a number of lawsuits in connection to its implant’s high failure rate, DePuy is also being sued by its rival over hip implant design.
  • 3. The DePuy ASR hip device has been fitted in 93,000 patients worldwide as stated in the company’s website. Of the 93,000 patients, 5,500 are Australians and most of them needed to undergo more than one revision surgeries. Patients fitted with the metal-on-metal hip implants also reported “serious and systemic health problems extending beyond the initial complications caused by the device.”
  • 4. The issue is described as a “ticking time bomb” facing many patients by the Senate committee. Aside from being told to prioritize alerting doctors, patients and the public about the issues associated with the DePuy devices, the Department of Health and Ageing was also told to look for options for treatment and the reporting of adverse outcomes.
  • 5. The committee also mandated the department to “consider the best ways to monitor the levels of cobalt, chromium and other toxic metals which have been recorded in patients who received the metal-on-metal hip implants."
  • 6. The issue highlighted major flaws in the way the Therapeutic Goods Administration (TGA) dealt with information detailing problems with the devices, said independent Senator Nick Xenophon, who had called for the inquiry into the DePuy implants. The TGA had allegedly not listened to the concerns raised about the devices until December 2009, more than a year after the concerns were raised, said Senator Xenophon. Patients had suffered from pain, multiple surgeries, extended hospital stays, financial loss and personal anguish, said committee chairwoman Greens Senator Rachel Siewert.
  • 7. It had taken three years for the product to be recalled after evidence came out that the implants had a high failure rate back in 2006 as pointed out by orthopaedic expert Stephen Graves at a Senate committee hearing last September. Anthony Bishop, the Australian head of Johnson & Johnson, had expressed the company’s regrets over the incident before the Senate committee last September. Johnson & Johnson reimbursed more than $21 million in claims to more than 3,500 patients in Australia who had registered with the company's claim processor.
  • 8. Bishop said that on legal grounds the company would not answer questions about its response to earlier advice of the product's failure and why it took so long to withdraw it. Australia was the first country to withdraw the two DePuy hip implants in December 2009.
  • 9. DePuy ASR lawsuit is not only rising in the United States but also in Australia after solicitors acting on behalf of people affected by the allegedly faulty hip implants filed an action against DePuy in the Federal Court last September seeking compensation for harm. The claimants are also seeking punitive damages on the basis that DePuy, owned by the medical giant Johnson & Johnson, allowed the products to remain on the market despite sufficient evidence showing the devices were causing harm.